Follow
Yogen Saunthararajah
Yogen Saunthararajah
Cleveland Clinic, Case Western Reserve University
Verified email at ccf.org
Title
Cited by
Cited by
Year
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment
MH Steinberg, F Barton, O Castro, CH Pegelow, SK Ballas, A Kutlar, ...
Jama 289 (13), 1645-1651, 2003
11562003
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ...
Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009
5272009
Inherited and somatic defects in DDX41 in myeloid neoplasms
C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ...
Cancer cell 27 (5), 658-670, 2015
4362015
Dynamics of clonal evolution in myelodysplastic syndromes
H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ...
Nature genetics 49 (2), 204-212, 2017
4252017
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ...
Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002
3752002
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ...
Leukemia 28 (1), 78-87, 2014
3612014
Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
Y Saunthararajah, CA Hillery, D Lavelle, R Molokie, L Dorn, L Bressler, ...
Blood 102 (12), 3865-3870, 2003
3232003
Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes
JJ Molldrem, E Leifer, E Bahceci, Y Saunthararajah, M Rivera, C Dunbar, ...
Annals of internal medicine 137 (3), 156-163, 2002
2972002
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
J Wang, Y Saunthararajah, RL Redner, JM Liu
Cancer research 59 (12), 2766-2769, 1999
2861999
Somatic SETBP1 mutations in myeloid malignancies
H Makishima, K Yoshida, N Nguyen, B Przychodzen, M Sanada, Y Okuno, ...
Nature genetics 45 (8), 942-946, 2013
2792013
Modification of hematopoietic stem cell fate by 5aza 2′ deoxycytidine and trichostatin A
M Milhem, N Mahmud, D Lavelle, H Araki, J DeSimone, Y Saunthararajah, ...
Blood 103 (11), 4102-4110, 2004
2532004
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome
Y Saunthararajah, R Nakamura, R Wesley, QJ Wang, AJ Barrett
Blood 102 (8), 3025-3027, 2003
2462003
Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
J Barrett, Y Saunthararajah, J Molldrem
Seminars in hematology 37 (1), 15-29, 2000
2422000
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
KI Ataga, WR Smith, LM De Castro, P Swerdlow, Y Saunthararajah, ...
Blood, The Journal of the American Society of Hematology 111 (8), 3991-3997, 2008
2402008
EVI1 induces myelodysplastic syndrome in mice
S Buonamici, D Li, Y Chi, R Zhao, X Wang, L Brace, H Ni, ...
The Journal of clinical investigation 114 (5), 713-719, 2004
2342004
Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies
H Makishima, AM Jankowska, RV Tiu, H Szpurka, Y Sugimoto, Z Hu, ...
Leukemia 24 (10), 1799-1804, 2010
2212010
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
V Visconte, HJ Rogers, J Singh, J Barnard, M Bupathi, F Traina, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3173-3186, 2012
2182012
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
JP Maciejewski, D Follmann, R Nakamura, Y Saunthararajah, CE Rivera, ...
Blood, The Journal of the American Society of Hematology 98 (13), 3513-3519, 2001
2032001
Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease
DJ Wilkie, R Molokie, D Boyd-Seal, ML Suarez, YO Kim, S Zong, H Wittert, ...
Journal of the National Medical Association 102 (1), 18-27, 2010
1782010
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ...
Leukemia 27 (6), 1301-1309, 2013
1652013
The system can't perform the operation now. Try again later.
Articles 1–20